Cargando…

Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma

Sphingosine kinase 1 (SPHK1) has been shown to be involved in the progression of various types of human cancers. We previously demonstrated that SPHK1 is overexpressed and associated with clinical stage, locoregional recurrence, distant metastasis and poor prognosis in nasopharyngeal carcinoma (NPC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wenhua, Li, Jian, Wang, Yunchao, Zhang, Keqian, Li, Ni, Tian, Zhiqiang, Ni, Bing, Wang, Huaizhi, Ruan, Zhihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348343/ https://www.ncbi.nlm.nih.gov/pubmed/27811359 http://dx.doi.org/10.18632/oncotarget.13014

Ejemplares similares

Sphingosine kinase 1 as an anticancer therapeutic target
por: Gao, Ying, et al.
Publicado: (2015)

Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma
por: Li, Jian, et al.
Publicado: (2023)

Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma
por: Li, Jian, et al.
Publicado: (2023)

An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma
por: Pan, Jian, et al.
Publicado: (2011)

The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target
por: Wang, Xianwang, et al.
Publicado: (2020)

Targeting Sphingosine Kinase by ABC294640 against Diffuse Intrinsic Pontine Glioma (DIPG)
por: Dai, Lu, et al.
Publicado: (2020)

Combined effects on leukemia cell growth by targeting sphingosine kinase 1 and sirtuin 1 signaling
por: Li, Yuxiang, et al.
Publicado: (2020)

Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma
por: Cai, Huajie, et al.
Publicado: (2017)

The emerging role of miR-506 in cancer
por: Li, Jian, et al.
Publicado: (2016)

Drugging Sphingosine Kinases
por: Santos, Webster L., et al.
Publicado: (2014)

MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma
por: Wang, Sumei, et al.
Publicado: (2019)

Upregulation of sphingosine kinase 1 is associated with recurrence and poor prognosis in papillary thyroid carcinoma
por: Li, Jie, et al.
Publicado: (2019)

Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy
por: Gupta, Preeti, et al.
Publicado: (2021)

Cardiovascular Effects of Pharmacological Targeting of Sphingosine Kinase 1
por: Józefczuk, Ewelina, et al.
Publicado: (2020)

N(6)-methyladenosine (m(6)A) in pancreatic cancer: Regulatory mechanisms and future direction
por: Li, Jian, et al.
Publicado: (2021)

Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer
por: Ochnik, Aleksandra M., et al.
Publicado: (2017)

Circular RNA: a novel biomarker and therapeutic target for human cancers
por: Lei, Bo, et al.
Publicado: (2019)

Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting
por: Alshaker, Heba, et al.
Publicado: (2019)

Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cells
por: Ng, Mei Li, et al.
Publicado: (2018)

Sphingosine kinase 1 is overexpressed and promotes adrenocortical carcinoma progression
por: Xu, Yunze, et al.
Publicado: (2015)

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021)

Therapeutic potential of targeting MKK3-p38 axis with Capsaicin for Nasopharyngeal Carcinoma
por: Chiang, Chengyao, et al.
Publicado: (2020)

Targeting sphingosine kinase 1 with LNA oligonucleotides in gastric cancer
por: Füreder, Thorsten, et al.
Publicado: (2008)

Potential of a sphingosine 1-phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment
por: Tanaka, Yuko, et al.
Publicado: (2022)

Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy
por: Liu, Guanglin, et al.
Publicado: (2010)

Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells
por: Lu, Pei-Hua, et al.
Publicado: (2017)

Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase
por: Liu, Jingxian, et al.
Publicado: (2019)

Significance of sphingosine kinase 1 expression in feline mammary tumors
por: Chang, Yi-Chih, et al.
Publicado: (2019)

Ubiquitination Destabilizes Protein Sphingosine Kinase 2 to Regulate Glioma Malignancy
por: Wang, Hongliang, et al.
Publicado: (2021)

Sphingosine Kinases/Sphingosine-1-Phosphate and Death Signalling in APP-Transfected Cells
por: Gassowska, Magdalena, et al.
Publicado: (2014)

Characterizing Sphingosine Kinases and Sphingosine 1-Phosphate Receptors in the Mammalian Eye and Retina
por: Porter, Hunter, et al.
Publicado: (2018)

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
por: Cannavo, Alessandro, et al.
Publicado: (2017)

The role of the sphingosine axis in immune regulation: A dichotomy in the anti-inflammatory effects between sphingosine kinase 1 and sphingosine kinase 2-dependent pathways
por: Ishay, Yuval, et al.
Publicado: (2021)

Sphingosine Kinase Activity Is Not Required for Tumor Cell Viability
por: Rex, Karen, et al.
Publicado: (2013)

Sphingosine kinase 1 mediates AGEs-induced fibronectin upregulation in diabetic nephropathy
por: Chen, Cheng, et al.
Publicado: (2017)

Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2
por: Aji, Gulibositan, et al.
Publicado: (2020)

Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer
por: Khan, Faez Iqbal, et al.
Publicado: (2019)

Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer
por: Kim, Hyun-Soo, et al.
Publicado: (2015)

An oncogenic role for sphingosine kinase 2
por: Neubauer, Heidi A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ffeaqvcjo728e3ma6mqiab9ff8